CAS 126382-01-2

1(3H)-Isobenzofuranone,5-hydroxy-7-methoxy-3-[5-[(2R,5R,7R)-2-methyl-1,6-dioxaspiro[4.5]dec-7-yl]pentyl]-,(3R)-

Description:

1(3H)-Isobenzofuranone, 5-hydroxy-7-methoxy-3-[5-[(2R,5R,7R)-2-methyl-1,6-dioxaspiro[4.5]dec-7-yl]pentyl]-, (3R)-, is a complex organic compound characterized by its unique structural features, including a fused isobenzofuranone ring system and a spirocyclic moiety. This compound exhibits a range of functional groups, including hydroxyl and methoxy groups, which contribute to its potential biological activity and solubility properties. The presence of stereocenters in its structure indicates that it may exist in multiple stereoisomeric forms, which can influence its reactivity and interactions in biological systems. Such compounds are often of interest in medicinal chemistry due to their potential pharmacological properties. The specific arrangement of atoms and functional groups in this molecule suggests it may participate in various chemical reactions, including hydrogen bonding and hydrophobic interactions, which are critical for its behavior in biological environments. Overall, this compound represents a fascinating area of study for researchers interested in organic synthesis and drug development.

Formula: C₂₃H₃₂O₆

Synonyms:

• 1(3H)-Isobenzofuranone,5-hydroxy-7-methoxy-3-[5-[(2R,5R,7R)-2-methyl-1,6-dioxaspiro[4.5]dec-7-yl]pentyl]-(9CI)
• 1,6-Dioxaspiro[4.5]decane, 1(3H)-isobenzofuranone deriv.
• (+)-Spirolaxine
• Spirolaxin
• (3R)-5-Hydroxy-7-methoxy-3-[5-[(2R,5R,7R)-2-methyl-1,6-dioxaspiro[4.5]decane-7-yl]pentyl]isobenzofuran-1(3H)-one
• 1(3H)-Isobenzofuranone, 5-hydroxy-7-methoxy-3-[5-[(2R,5R,7R)-2-methyl-1,6-dioxaspiro[4.5]dec-7-yl]pentyl]-, (3R)-

Spirolaxine

CAS: 126382-01-2

Spirolaxine from Sporotrichum laxum shows anti-Helicobacter pylori activity.

Formula: C₂₃H₃₂O₆

Purity: 98%

Color and Shape: Solid

Molecular weight: 404.5

Ref: TM-T28834

Spirolaxine

CAS: 126382-01-2

Spirolaxine is a coumarin derivative that has been shown to have anti-cancer properties. It was isolated from an extract of the fungus Spirolaxine, which was found in the gastroduodenum (gut) of a frog. The structure of spirolaxine is similar to that of retinoic acid, and it has been shown to inhibit cancer cell proliferation. Spirolaxine also inhibits the production of proinflammatory cytokines in mice with colitis. This drug has not yet been tested for its ability to treat other diseases, such as diabetes, but may be able to regulate blood sugar levels by inhibiting insulin secretion and increasing glucose uptake by cells.

Formula: C₂₃H₃₂O₆

Purity: Min. 95%

Molecular weight: 404.5 g/mol

Ref: 3D-BFA38201